With RFK Jr. appointment for HHS, biopharma industry could face powerful adversary in government

After pledging to allow politician and vaccine skeptic Robert Francis Kennedy Jr. (RFK Jr.), to “go wild” on health and medicines, president-elect Donald Trump has seemingly made good on his promise with his official nomination for the next U.S. Secretary of Health and Human Services (HHS).